DISEASE SCANNER
Global Incurable Diseases Tracker
Testicular Cancer
The most common solid tumor in young men (15-35 years). Two main types: germ cell tumors (seminoma and non-seminoma) and non-germ cell tumors. Highly curable even when metastatic. Associated with cryptorchidism and family history.
75.0K
18
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Biopsy
- 2Imaging (CT, MRI, PET)
- 3Tumor markers
- 4Genetic testing
- 5Endoscopy
- 6Blood tests
- 7Screening programs
Prognosis
Excellent prognosis overall - most curable solid tumor. Stage I: 5-year survival 99%. Stage II: 5-year survival 95-96%. Stage III: 5-year survival 70-80% depending on tumor markers. Seminoma has slightly better prognosis than non-seminoma. Cisplatin-based chemotherapy curative in 90% of advanced cases. Fertility may be affected by treatment. Surveillance appropriate for Stage I. Relapse after complete response rare (<5%). Long-term survivors may experience late effects of chemotherapy.
Prevention
- Smoking cessation
- Sun protection
- Healthy diet
- Regular exercise
- Vaccination (HPV, HBV)
- Screening programs
- Limit alcohol
- Maintain healthy weight
Research Status
Orchiectomy for diagnosis/treatment. Platinum-based chemotherapy (BEP) for metastatic disease. Retroperitoneal lymph node dissection. Radiation for seminoma. Survival >95% overall; 70-80% even with metastases. Excellent prognosis.
Affected Countries
Sources
- https://www.cancer.gov
- https://www.who.int/cancer
- https://www.cancer.org
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.